[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2013008647A - Metodo, composiciones y empaque para limpieza del intestino. - Google Patents

Metodo, composiciones y empaque para limpieza del intestino.

Info

Publication number
MX2013008647A
MX2013008647A MX2013008647A MX2013008647A MX2013008647A MX 2013008647 A MX2013008647 A MX 2013008647A MX 2013008647 A MX2013008647 A MX 2013008647A MX 2013008647 A MX2013008647 A MX 2013008647A MX 2013008647 A MX2013008647 A MX 2013008647A
Authority
MX
Mexico
Prior art keywords
package
composition
bowel cleansing
cleansing
formulation
Prior art date
Application number
MX2013008647A
Other languages
English (en)
Other versions
MX346936B (es
Inventor
William A Shaver
Original Assignee
William A Shaver
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William A Shaver filed Critical William A Shaver
Publication of MX2013008647A publication Critical patent/MX2013008647A/es
Publication of MX346936B publication Critical patent/MX346936B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención provee una formulación de limpieza del colon altamente agradable al paladar que utiliza una solución básica de reabastecimiento de electrolito de bajo contenido de cloruro. Cuando es formulada con polietilenglicol y un alcohol de azúcar seleccionado, la formulación ofrece las ventajas de sabor agradable superior sin efectos secundarios concomitantes indeseables o una disminución en la eficacia de limpieza.
MX2013008647A 2011-01-28 2011-12-13 Metodo, composiciones y empaque para limpieza del intestino. MX346936B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161462094P 2011-01-28 2011-01-28
PCT/US2011/064670 WO2012102799A2 (en) 2011-01-28 2011-12-13 Method, composition and package for bowel cleansing

Publications (2)

Publication Number Publication Date
MX2013008647A true MX2013008647A (es) 2013-11-04
MX346936B MX346936B (es) 2017-04-05

Family

ID=45507871

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008647A MX346936B (es) 2011-01-28 2011-12-13 Metodo, composiciones y empaque para limpieza del intestino.

Country Status (12)

Country Link
US (7) US8753618B2 (es)
EP (1) EP2667900B1 (es)
JP (2) JP5870119B2 (es)
KR (1) KR20140012980A (es)
CN (2) CN105963701A (es)
AU (1) AU2011356598B2 (es)
BR (1) BR112013019360A2 (es)
CA (1) CA2825808C (es)
IL (1) IL227655B (es)
MX (1) MX346936B (es)
RU (1) RU2651751C2 (es)
WO (1) WO2012102799A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012102799A2 (en) 2011-01-28 2012-08-02 Shaver William A Method, composition and package for bowel cleansing
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
JP6240610B2 (ja) * 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ，インコーポレイテッド 電解質下剤
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
MX359318B (es) 2012-09-11 2018-09-25 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
MX2015012109A (es) 2013-03-15 2016-04-15 Braintree Lab Composicion farmaceutica oral de sales sulfato para comprimidos de uso dual y metodos para su uso.
KR101423005B1 (ko) * 2013-10-17 2014-07-28 강윤식 장 세정용 조성물
WO2015056897A1 (ko) * 2013-10-17 2015-04-23 강윤식 장 세정용 조성물
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
US20160263152A1 (en) * 2015-03-14 2016-09-15 Gavis Pharmaceuticals Bowel cleansing composition with improved taste
US20180318234A1 (en) * 2015-06-22 2018-11-08 Ctc Bio, Inc. Purgative composition for cleansing intestinal tract
JP2018523694A (ja) 2015-08-17 2018-08-23 フェリング ベスローテン フェンノートシャップ ピコスルファートおよびクエン酸マグネシウムを含む液体製剤
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
MA45584A (fr) * 2016-07-06 2021-04-07 Nogra Pharma Ltd Formules contre le vieillissement.
CN113825739A (zh) 2019-02-08 2021-12-21 诺格拉制药有限公司 制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法
CN110433174A (zh) * 2019-07-17 2019-11-12 华南理工大学 一种高依从性的复方聚乙二醇电解质散剂及其制备方法与应用
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
US11793876B2 (en) 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
PL243659B1 (pl) * 2020-10-30 2023-09-25 Biogliko Spolka Z Ograniczona Odpowiedzialnoscia Sucha kompozycja do rozpuszczania w wodzie

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231356A1 (en) * 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
DE3889547T2 (de) 1987-12-24 1994-11-17 Borody Thomas J Orthostatische waschlösungen.
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
JP2721929B2 (ja) 1990-01-30 1998-03-04 株式会社大塚製薬工場 腸管洗浄用組成物
JP3284620B2 (ja) 1992-10-16 2002-05-20 トヨタ自動車株式会社 アンチスキッド制御装置
US5445805A (en) * 1993-05-06 1995-08-29 Church & Dwight Co., Inc. Large potassium bicarbonate crystals and process for the preparation thereof
RU2111741C1 (ru) * 1994-10-27 1998-05-27 Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации Вещество для общего промывания желудочно-кишечного тракта
US6103268A (en) 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
US6444198B1 (en) * 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
EA003064B1 (ru) * 1999-02-22 2002-12-26 Смитклайн Бичем Корпорейшн Шипучие слабительные средства
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
ATE477790T1 (de) * 2001-10-29 2010-09-15 Ajinomoto Kk Lösung zur darmreinigung
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US8361452B2 (en) 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US7291324B2 (en) 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7332184B2 (en) 2003-03-28 2008-02-19 Queen's University At Kingston Colonic cleansing composition and method
JP2004323456A (ja) * 2003-04-28 2004-11-18 Shimizu Pharmaceutical Co Ltd 腸管洗浄製剤
US7049319B2 (en) 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
ES2247897B1 (es) * 2003-12-18 2007-05-01 Gat Formulation Gmbh Tabletas con matriz polimerica emulsionada para emision controlada de gases y procedimiento para su fabricacion.
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US20060051428A1 (en) * 2004-09-03 2006-03-09 Nelson Ayala Aspartame and citrate flavored phosphate salt laxative
CA2607250C (en) * 2005-05-06 2012-11-06 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
JP4781071B2 (ja) 2005-09-28 2011-09-28 三洋電機株式会社 電源装置と電池の冷却方法
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
KR101529702B1 (ko) 2008-10-09 2015-06-17 가부시키가이샤 유야마 세이사쿠쇼 약제 포장유니트 및 이의 포장 제어방법
US8470983B2 (en) * 2009-06-03 2013-06-25 Aptalis Pharma Canada Inc. L-sugar colon cleansing agent and uses thereof
WO2012102799A2 (en) 2011-01-28 2012-08-02 Shaver William A Method, composition and package for bowel cleansing

Also Published As

Publication number Publication date
BR112013019360A2 (pt) 2017-03-28
IL227655A0 (en) 2013-09-30
CN105963701A (zh) 2016-09-28
US20220233482A1 (en) 2022-07-28
US20150056307A1 (en) 2015-02-26
US9566300B2 (en) 2017-02-14
RU2013138672A (ru) 2015-03-20
IL227655B (en) 2020-10-29
US11241404B2 (en) 2022-02-08
AU2011356598A2 (en) 2013-09-05
KR20140012980A (ko) 2014-02-04
JP2014504612A (ja) 2014-02-24
US20190029983A1 (en) 2019-01-31
US20200405670A1 (en) 2020-12-31
AU2011356598B2 (en) 2017-06-01
US8753618B2 (en) 2014-06-17
US20160243158A1 (en) 2016-08-25
EP2667900B1 (en) 2020-02-12
JP5870119B2 (ja) 2016-02-24
US20120195980A1 (en) 2012-08-02
JP2016117740A (ja) 2016-06-30
WO2012102799A2 (en) 2012-08-02
US9211337B2 (en) 2015-12-15
MX346936B (es) 2017-04-05
WO2012102799A3 (en) 2012-10-18
US10052295B2 (en) 2018-08-21
CN103391790B (zh) 2016-06-15
US10596135B2 (en) 2020-03-24
AU2011356598A1 (en) 2013-09-05
CN103391790A (zh) 2013-11-13
CA2825808A1 (en) 2012-08-02
EP2667900A2 (en) 2013-12-04
RU2651751C2 (ru) 2018-04-23
CA2825808C (en) 2020-09-01
US20170189360A1 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
MX346936B (es) Metodo, composiciones y empaque para limpieza del intestino.
GB201106750D0 (en) Novel compounds
MY179756A (en) Stabilized efinaconazole formulations
SG194469A1 (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors
HUE060743T2 (hu) Gyógyszerészeti kompozíciók, amelyek tartalmaznak imidazothiadiazol- és imidazopiridazinszármazékokat mint proteáz aktívált receptor 4 (PAR4) inhibitorokat trombocitaaggregációk kezelésére
GB2514951C (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
WO2012076293A9 (de) Zubereitungen enthaltend polysiloxane mit stickstoffhaltigen gruppen
PH12012501755A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2013173789A3 (en) Antisense oligonucleotide compositions
WO2014039903A3 (en) Stable aqueous formulations of adalimumab
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
MX360065B (es) Inhibidores cristalinos de bromodominio.
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
PH12014501991B1 (en) Phenicol antibacterials
IL227626A0 (en) A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses
PH12015500900A1 (en) A stabilized pemetrexed formulation
MX2014014468A (es) Compuestos triazolo como inhibidores de fosfodiesterasa 10 (pde10).
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
NZ607997A (en) Fungicidal bactericidal and/or antioxidant treatment of foodstuffs via application of formulations comprising an essential oil and a dialkylene glycol
HK1208188A1 (en) Formulations for the delivery of active ingredients
WO2011124570A3 (en) Oral film formulation
IT1401289B1 (it) Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
MX2014015199A (es) Formulacion de pexiganan estable.
IT1399492B1 (it) Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: WILLIAM A. SHAVER

Owner name: BRAINTREE LABORATORIES, INC.

FG Grant or registration